Floatz logo

Umbilical Cord Blood Cell Infusion

Non-Hodgkin's Lymphoma

Mesoblast, Ltd.Cell therapyPhase 3Dormant
B
56/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
47/ 100
Competitive Position
73/ 100

Competitive context

411 Active assets in the Non-Hodgkin's Lymphoma cohort.

Asset / SponsorPhaseRating
CYCLOSPORIN A
Memorial Sloan Kettering Cancer Center
Phase 3BBB
PEGASPARGASE
Ciusss de L'Est de l'Île de Montréal
Phase 4BBB
Inno-206
National Cancer Institute (NCI)
Phase 4BBB
CHLOROPTIC-P S.O.P. COMPONENT PREDNISOLONE
Mwanasha Merrill, MD
Phase 3BBB
Entecavir
Fudan University
Phase 4BBB

View all 50 →

Same molecule, other indications

Umbilical Cord Blood Cell Infusion is also rated in:

Hodgkins lymphomaDormant
B
Indicative ·
62 / 100
View asset →
acute myeloid leukemiaDormant
B
Indicative ·
61 / 100
View asset →
acute lymphoblastic leukemiaDormant
CCC
Indicative ·
53 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →